company background image
U01 logo

Delivra Health Brands DB:U01 Stock Report

Last Price

€0.0035

Market Cap

€3.2m

7D

-46.2%

1Y

-46.2%

Updated

08 Jan, 2025

Data

Company Financials +

My Notes

Capture your thoughts, links and company narrative

Delivra Health Brands Inc. Competitors

Price History & Performance

Summary of share price highs, lows and changes for Delivra Health Brands
Historical stock prices
Current Share PriceCA$0.0035
52 Week HighCA$0.036
52 Week LowCA$0.0015
Beta1.03
1 Month Change0%
3 Month Change-58.82%
1 Year Change-46.15%
3 Year Change-89.58%
5 Year Change-96.31%
Change since IPO-99.02%

Recent News & Updates

Recent updates

Shareholder Returns

U01DE PharmaceuticalsDE Market
7D-46.2%3.4%2.0%
1Y-46.2%-14.7%9.6%

Return vs Industry: U01 underperformed the German Pharmaceuticals industry which returned -14.7% over the past year.

Return vs Market: U01 underperformed the German Market which returned 9.6% over the past year.

Price Volatility

Is U01's price volatile compared to industry and market?
U01 volatility
U01 Average Weekly Movement117.5%
Pharmaceuticals Industry Average Movement5.6%
Market Average Movement4.9%
10% most volatile stocks in DE Market11.7%
10% least volatile stocks in DE Market2.4%

Stable Share Price: U01's share price has been volatile over the past 3 months compared to the German market.

Volatility Over Time: U01's weekly volatility has increased from 79% to 117% over the past year.

About the Company

FoundedEmployeesCEOWebsite
n/an/aGord Daveydelivrahealthbrands.com

Delivra Health Brands Inc., through its subsidiaries, provides lifestyle, health, and wellness products to consumers and patients worldwide. The company offers cannabis, liquid sleep shots, sleep powder packets, gummies, and pain relief creams. It sells its products under LivRelief, Dream Water, and LivRelief infused brands.

Delivra Health Brands Inc. Fundamentals Summary

How do Delivra Health Brands's earnings and revenue compare to its market cap?
U01 fundamental statistics
Market cap€3.16m
Earnings (TTM)€115.93k
Revenue (TTM)€8.00m

27.3x

P/E Ratio

0.4x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
U01 income statement (TTM)
RevenueCA$11.87m
Cost of RevenueCA$5.80m
Gross ProfitCA$6.08m
Other ExpensesCA$5.90m
EarningsCA$172.00k

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)0.00055
Gross Margin51.18%
Net Profit Margin1.45%
Debt/Equity Ratio44.3%

How did U01 perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/08 02:04
End of Day Share Price 2025/01/08 00:00
Earnings2024/09/30
Annual Earnings2024/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Delivra Health Brands Inc. is covered by 3 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Siddharth RajeevFundamental Research Corp.
Neal GilmerHaywood Securities Inc.
Greg McLeishResearch Capital Corporation